These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 20467380

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.
    Mathew S, Davies M, Lund R, Saab G, Hruska KA.
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():43-50. PubMed ID: 16884397
    [Abstract] [Full Text] [Related]

  • 3. [Chronic kidney disease-mineral and bone disorder (CKD-MBD)].
    Hamada Y, Fukagawa M.
    Nihon Rinsho; 2006 Sep; 64(9):1703-6. PubMed ID: 16972683
    [Abstract] [Full Text] [Related]

  • 4. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Pimentel A, Ureña-Torres P, Zillikens MC, Bover J, Cohen-Solal M.
    Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
    [Abstract] [Full Text] [Related]

  • 5. [Mineral and bone disturbances associated with chronic kidney disease].
    Suchowierska E, Myśliwiec M.
    Pol Merkur Lekarski; 2010 Feb; 28(164):138-43. PubMed ID: 20369744
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
    Hsu CY, Chen LR, Chen KH.
    Int J Mol Sci; 2020 Sep 18; 21(18):. PubMed ID: 32961953
    [Abstract] [Full Text] [Related]

  • 9. [Kidney and bone update : the 5-year history and future of CKD-MBD. About the guideline of the Japanese Society for Dialysis Therapy].
    Yokoyama K.
    Clin Calcium; 2012 Jul 18; 22(7):979-86. PubMed ID: 22750929
    [Abstract] [Full Text] [Related]

  • 10. Vascular calcification and renal osteodystrophy relationship in chronic kidney disease.
    Moe SM.
    Eur J Clin Invest; 2006 Aug 18; 36 Suppl 2():51-62. PubMed ID: 16884398
    [Abstract] [Full Text] [Related]

  • 11. The role of fibroblast growth factor 23 in chronic kidney disease-mineral and bone disorder.
    Diniz H, Frazão JM.
    Nefrologia; 2013 Nov 13; 33(6):835-44. PubMed ID: 24158124
    [Abstract] [Full Text] [Related]

  • 12. Current concepts and management strategies in chronic kidney disease-mineral and bone disorder.
    Chauhan V, Kelepouris E, Chauhan N, Vaid M.
    South Med J; 2012 Sep 13; 105(9):479-85. PubMed ID: 22948328
    [Abstract] [Full Text] [Related]

  • 13. High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease.
    Lau WL, Linnes M, Chu EY, Foster BL, Bartley BA, Somerman MJ, Giachelli CM.
    Nephrol Dial Transplant; 2013 Jan 13; 28(1):62-9. PubMed ID: 23045434
    [Abstract] [Full Text] [Related]

  • 14. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.
    Williams MJ, Sugatani T, Agapova OA, Fang Y, Gaut JP, Faugere MC, Malluche HH, Hruska KA.
    Kidney Int; 2018 Jan 13; 93(1):147-158. PubMed ID: 28843411
    [Abstract] [Full Text] [Related]

  • 15. Mineral bone disorders in chronic kidney disease.
    Hou YC, Lu CL, Lu KC.
    Nephrology (Carlton); 2018 Oct 13; 23 Suppl 4():88-94. PubMed ID: 30298663
    [Abstract] [Full Text] [Related]

  • 16. Relationship between aortic mineral elements and osteodystrophy in mice with chronic kidney disease.
    Matsumoto T, Fukushima S, Kanasaki T, Hagino S.
    Biol Trace Elem Res; 2012 Dec 13; 150(1-3):278-84. PubMed ID: 22700181
    [Abstract] [Full Text] [Related]

  • 17. Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder.
    Hanudel MR, Salusky IB.
    Curr Osteoporos Rep; 2017 Jun 13; 15(3):198-206. PubMed ID: 28455644
    [Abstract] [Full Text] [Related]

  • 18. Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy.
    Sabbagh Y, Graciolli FG, O'Brien S, Tang W, dos Reis LM, Ryan S, Phillips L, Boulanger J, Song W, Bracken C, Liu S, Ledbetter S, Dechow P, Canziani ME, Carvalho AB, Jorgetti V, Moyses RM, Schiavi SC.
    J Bone Miner Res; 2012 Aug 13; 27(8):1757-72. PubMed ID: 22492547
    [Abstract] [Full Text] [Related]

  • 19. [Changes to calcium-phosphate metabolism associated with chronic nephropathies].
    Blahoš J, Sotorník I.
    Vnitr Lek; 2012 Aug 13; 58(7-8):512-8. PubMed ID: 23067156
    [Abstract] [Full Text] [Related]

  • 20. The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives.
    Carvalho C, Alves CM, Frazão JM.
    J Nephrol; 2016 Oct 13; 29(5):617-26. PubMed ID: 27473148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.